Total (n = 25) | LPLNM (n = 8) | Non-LPLNM (n = 17) | p | |
---|---|---|---|---|
Age, years | 63 (44–84) | 65.5 (44–84) | 76 (44–81) | 0.662 |
Sex (male/female) | 20/5 | 7/1 | 13/4 | 1.000 |
BMI, kg/m2 | 22.4 (18.6–28.0) | 22.85 (19.4–28.0) | 22.4 (18.6–26.7) | 0.641 |
ASA-PS (1/2/3) | 11/11/3 | 4/3/1 | 7/8/2 | 1.000 |
Abddominal surgical history | 5 (20.0%) | 2 (25.0%) | 3 (17.6%) | 1.000 |
Preoperative chemotherapy | 4 (16.0%) | 3 (17.6%) | 1 (12.5%) | 1.000 |
Preoperative chemoradiotherapy | 5 (20.0%) | 2 (11.8%) | 3 (37.5%) | 0.283 |
Tumor | ||||
pT (1/2/3/4/LPLNR) | 3/5/13/3/1 | 0/3/2/2/1 | 3/2/11/1/0 | 0.049 |
pN (0/1/2/3/LPLNR) | 12/5/0/7/1 | 0/0/7/1 | 12/5/0/0 | > 0.001 |
cM (0/1/LPLNMR) | 21/3/1 | 7/0/1 | 14/3/0 | 0.188 |
Differentiation (moderate or high/low) | 22/3 | 5/3 | 17/0 | 0.024 |
L (0/1/X) | 7/16/2 | 1/5/2 | 6/11/0 | 0.108 |
V (0/1/X) | 7/15/3 | 3/3/2 | 4/12/1 | 0.263 |
Surgery | ||||
Procedure (AR/ISR/APR/TPE) | 12/3/9/1 | 6/0/2/0 | 3/3/10/1 | 0.051 |
Robot/Laparoscopy | 18/7 | 6/2 | 12/5 | 1.000 |
taTME | 22 (88.0%) | 16 (75.0%) | 6 (94.1%) | 0.231 |
Diverting stoma | 14 (56.0%) | |||
Operative time, min | 479 (240–867) | 549.5 (417–678) | 413 (240–867) | 0.140 |
Blood loss, ml | 65 (0–760) | 68 (30–160) | 65 (0–760) | 0.502 |
Dissected lateral lymph nodes | 12 (2–24) | 11 (5–23) | 12 (2–24) | 0.930 |